School of Medicine
Showing 121-130 of 148 Results
-
Shih-Po Su
Postdoctoral Scholar, Ophthalmology
BioDr. Shih-Po Su is a Postdoctoral Research Fellow in the Department of Ophthalmology at Stanford University. He earned his Ph.D. in Biomedical Engineering from National Yang Ming Chiao Tung University (NYCU), Taiwan, in 2024. His doctoral research focused on the development of advanced optical imaging systems, including a three-dimensional near-infrared fluorescence and photoacoustic vascular imaging platform for preclinical applications.
Dr. Su has over a decade of experience in biomedical imaging, integrating optical system design, image analysis, and in vivo disease modeling. His research interests center on the interface of optical engineering and translational medicine, particularly in retinal ganglion cell (RGC) imaging and neuroprotective strategies for glaucoma. At Stanford, he is extending his expertise to short-wave infrared (SWIR/NIR-II) imaging and in vivo retinal functional imaging to establish sensitive biomarkers for neurodegeneration.
His recent work has advanced optical imaging and NIR-II contrast agents, including the co-development of polymer-dot probes for three-dimensional tumor and bone imaging (Chemical Science, 2022; Advanced Healthcare Materials, 2021) and an ultrabright polymer-dot platform for rotational stereo imaging (Advanced Healthcare Materials, 2024). He also designed integrated small-animal imaging systems combining bioluminescence tomography and ultrasound, as well as rotational stereo NIR-II fluorescence imaging (Optics Express, 2024; Journal of Biomedical Optics, 2023; Biosensors, 2022).
Dr. Su has received multiple international recognitions, including the Taiwan Science and Technology Hub@Stanford Postdoctoral Fellowship (2024), First Prize in the NYCU Annual Thesis Competition (2023), the Future Tech Award (MOST, 2022), and the MOST Pilot Scholarship Program (2019). His long-term goal is to develop regenerative medicine–based imaging and therapeutic platforms to address unmet clinical needs in neurodegenerative diseases and vision restoration. -
Barathi Subramanian
Postdoctoral Scholar, Pathology
BioMy research lies at the intersection of computer vision and deep learning, focusing on the development of intelligent systems to advance large-scale image analytics in computational pathology, emphasizing histopathology-based survival analysis, whole slide image classification, and multi-modal representation learning. Through this research, I aim to bridge perceptual understanding and medical reasoning, enabling models to achieve high predictive accuracy and offer clinically interpretable insights for precision medicine.
-
Sriram Sudarsanam
Postdoctoral Scholar, Neurosurgery
BioSriram is broadly interested in how cellular interactions shape neurodevelopment. He completed his undergraduate studies at the Indian Institute of Science, and Masters at the Weizmann Institute. His doctoral research in Alex Kolodkin’s laboratory at Johns Hopkins addressed the development of idiosyncratic axonal arborization patterns of cortical neurons. He developed genetic strategies to visualize and perturb sparse populations of neurons in the mouse brain, using which he identified novel molecular and cellular determinants of spatially-restricted axon branching in vivo.
Now, as a postdoctoral scholar in Brad Zuchero's laboratory, Sriram is working to develop novel genetic tools to observe and perturb neuron-oligodendrocyte interactions in vivo. In collaboration with Ivan Soltesz’s laboratory, he aims to employ these tools to understand how myelination regulates neural circuit assembly and function. -
Takeshi Sugio
Postdoctoral Scholar, Oncology
BioI am a physician-scientist and hematologist focused on clinical translation of T-cell biology. I received my MD from Kyushu University, and subsequently completed Residency Training at Toranomon Hospital, the largest transplant center in Japan. I continued my Hematology training at Kyushu University, where I qualified as a Board-certified specialist (2017) and supervisory hematologist (2021) by the Japanese Society of Hematology. For my PhD (2014-19), I studied expression profiles and histologic features of TCLs. I discovered distinct TCL clinical groups identified by infiltrating immune cell patterns in the microenvironment. Based on my dissertation work (Sugio, et al 2018 Blood Advances), I planned and conducted a Phase II trial of PD1 inhibition for relapsed/refractory TCL (UMIN000034499). I joined the Alizadeh lab at Stanford in 2021, where I am developing tools to analyze immune status using liquid biopsies.
-
Ayesha Sujan
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioAyesha C. Sujan, PhD, is a licensed clinical psychologist with specialized clinical training in pediatric pain psychology and extensive research experience in pharmacoepidemiology, particularly in using large administrative datasets to study central nervous system medication and substance use during pregnancy. She is currently a postdoctoral fellow under the primary mentorship of Dr. Jennifer Rabbitts, Chief of Pediatric Pain, in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine, and is supported by an NIH T32 training grant (T32GM089626) focused on developing leaders in academic anesthesiology and pain medicine research. In addition to contributing to Dr. Rabbitts’ NIH-funded research on mechanisms and treatment of pain in youth undergoing surgery, she leads independent studies on pediatric chronic abdominal pain and disorders of gut–brain interaction, with a growing focus on central nervous system medication treatment for these conditions. Clinically, she conducts psychosocial assessments and provides evidence-based pain psychology treatment one day per week (20% FTE) in the outpatient pediatric pain management clinic at Stanford University School of Medicine, ensuring strong clinical grounding and translational relevance of her research program.
-
Han Sun
Postdoctoral Scholar, Genetics
Biostatistician 2, Pediatrics - EndocrinologyBioHan had been a postdoc with Dr. Steinmetz at the genetics department for five years, working on both cancers and heart diseases, trying to understand the mechanisms linking from variants to disease phenotypes. This led to a few very interesting findings of aberrant splicing regulation, such as splicing-mediated readthrough stabilization (SRS), one more mechanism for oncogene activation in multiple types of cancers, and tissue-specific splicing of a mitochondrial inner membrane protein, suggesting a molecular connection between deficiency in energy-supplying and dilated cardiomyopathy.
After being a senior computational biologist with Dr. Gloyn, who has been dedicated to the research of type 2 diabetes for decades, Han switched to the field of this multifactorial metabolic disease. It did take some courage to make such a switch at his post-postdoc stage, however, Han has a consistent interest in studying PG&E, which is not pacific gas and electric nearby, but the interaction between phenotype, genotype, and environment. With years of hands-on experience in statistical modeling and the analysis of next-generation sequencing and mass spectrometry data, in addition to a good understanding of disease genetics, cancer biology, and systems biology, Han is highly confident that he will enjoy the adventure and contribute to our understanding of diabetes.
